{"result": {"id": "80c86934-3186-4c51-89d8-173d94301734", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>PHENTOLAMINE<|>ORGANIZATION<|>Phentolamine is a medication used to treat hypertensive episodes, including those during surgery, and for diagnosing pheochromocytoma based on blood pressure response>  \n##  \n(\"entity\"<|>NICARDIPINE<|>ORGANIZATION<|>Nicardipine is a calcium channel blocker used for perioperative hypertension, hypertensive emergencies, and pregnancy-induced hypertension, with potential side effects like tachycardia and headache>  \n##  \n(\"entity\"<|>ESMOLOL<|>ORGANIZATION<|>Esmolol is a beta-blocker administered intravenously for hypertensive emergencies, with effects like hypotension and nausea>  \n##  \n(\"entity\"<|>METOPROLOL<|>ORGANIZATION<|>Metoprolol is a beta-blocker used for perioperative hypertension, with side effects including hypotension, heart failure, and bronchospasm>  \n##  \n(\"entity\"<|>LABETALOL<|>ORGANIZATION<|>Labetalol is an alpha- and beta-blocker used for perioperative hypertension, with side effects like nausea, bronchospasm, and orthostatic hypotension>  \n##  \n(\"entity\"<|>URAPIDIL<|>ORGANIZATION<|>Urapidil is an antihypertensive drug used for hypertensive emergencies, with side effects like dizziness and fatigue>  \n##  \n(\"entity\"<|>ENALAPRILAT<|>ORGANIZATION<|>Enalaprilat is an ACE inhibitor used intravenously for hypertension, with a risk of sharp blood pressure drops in high-renin states>  \n##  \n(\"entity\"<|>DILTIAZEM<|>ORGANIZATION<|>Diltiazem is a calcium channel blocker used for perioperative hypertension and hypertensive emergencies, with side effects like bradycardia and AV block>  \n##  \n(\"entity\"<|>HYDRALAZINE<|>ORGANIZATION<|>Hydralazine is a vasodilator used for hypertension, with side effects like tachycardia, headache, and hepatotoxicity>  \n##  \n(\"entity\"<|>FENOLDOPAM<|>ORGANIZATION<|>Fenoldopam is a dopamine agonist used for hypertensive emergencies, with side effects like tachycardia and nausea>  \n##  \n(\"entity\"<|>MAGNESIUM SULFATE<|>ORGANIZATION<|>Magnesium sulfate is used for severe preeclampsia and pregnancy-induced hypertension, with monitoring required for toxicity signs>  \n##  \n(\"relationship\"<|>NICARDIPINE<|>MAGNESIUM SULFATE<|>Nicardipine and magnesium sulfate are both used for pregnancy-induced hypertension, with potential interaction risks<|>4>  \n##  \n(\"relationship\"<|>ESMOLOL<|>METOPROLOL<|>Both are beta-blockers used for hypertension, with similar mechanisms but different durations of action<|>6>  \n##  \n(\"relationship\"<|>LABETALOL<|>URAPIDIL<|>Both are used for perioperative hypertension and hypertensive emergencies, with overlapping side effects<|>5>  \n##  \n(\"relationship\"<|>DILTIAZEM<|>HYDRALAZINE<|>Both treat perioperative hypertension, but with different mechanisms and side effect profiles<|>4>  \n##  \n(\"relationship\"<|>ENALAPRILAT<|>HYDRALAZINE<|>Both are antihypertensives, but enalaprilat is an ACE inhibitor while hydralazine is a vasodilator<|>3>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165523, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 802, "prompt_tokens": 2537, "total_tokens": 3339, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 745}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 、呕吐\n酚妥拉明\t发作，包括手术切除时出现的高血压，也可根据血压对本品 的反应用于协助诊断嗜铬细胞瘤)\t1~2min\t10~30 min\t心动过速、头痛、潮红\n\n尼卡地平\t●0.5~10μg-kg?1 ·min?1静脉注射(围术期高血压，高血压急症)\n●起始剂量5mg/h,据血压反应逐渐增加至15mg/h(妊娠高血 压，安全级别C级)\n·0.15~0.3mg ·kg1min1泵入(围术期高血压)\t\n5~10 min\t\n1~4h\t心动过速、头痛、周围水肿、心绞痛、 恶心、头晕，与硫酸镁合用可能抑  制子宫收缩\n艾司洛尔\t·250~500 μg/kg静脉注射继以50~300 μg ·kg' ·min1静脉滴注 (高血压急症)\t1~2min\t10~20 min\t低血压、恶心\n美托洛尔\t●3~5mg静脉推注，间隔5min重复，最大可用到15mg(围术 期高血压)\t5~10min\t5~10h\t低血压、心力衰竭、心脏传导阻滞、 头晕、疲劳、抑郁、支气管痉挛\n拉贝洛尔\t●25~50 mg静脉注射，间隔15min可重复，总量可达200 mg; 也可静脉泵入，1~4mg/min(围术期高血压)\t5~10 min\t3~6h\t恶心、呕吐、头皮刺痛、支气管痉挛、传导 阻滞、体位性低血压\n\n乌拉地尔\t　·20~80 mg静脉注射，0.5~2.0 mg/min静脉滴注(高血压急症) ●10~50 mg静脉注射\n·6~24  mg/h\t\n5min\t\n2~8h\t\n低血压、头晕、恶心、疲倦\n依那普利拉\t·1.25~5mg/6h静脉注射\t15~30min\t6~12h\t高肾素状态血压陡降、变异度较大\n\n地尔硫草\t· 5~10mg静脉注射，或5~15μg ·kg?1 ·min?1泵入(围术期高血 压、高血压急症)\t\n5min\t\n30 min\t心动过缓、房室传导阻滞、低血压、 心力衰竭、外周水肿、头痛、便秘、\n\n肼苯哒嗪\t\n· 10~20mg静脉注射\n· 10~40 mg肌肉注射\t\n10~20min; 20~30min\t\n　1~4h; 4~6h\t肝毒性\n心动过速、潮红、头痛、呕吐、心绞痛 加重\n非诺多泮\t●0.03~1.6μg · kg?1min?1静脉注射\n·5g稀释至20ml,静脉慢推5min,继以1~2g/h维持；或5g稀\t<5min\t30 min\t　心动过速、头痛、恶心、潮红  当尿量<600 ml/d、呼吸<16次/min、\n硫酸镁“\t释至20ml,每4小时一次深部肌肉注射，总量25~30 g/d(妊 娠高血压、严重先兆子痫)\t-\t\t腱反射消失时应及时停药\n注：“非高血压药物；�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_5dafaec8d77e9909dec34f2df0975ea65bbca6b6743d87a5416d0abb2ef50250_v2"}